SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,775.00    80.00 (1.19%)
Bid:
6,770.00
Ask:
6,780.00
Spread: 10.00 (0.148%)
Market Cap: £5.00b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Acquisition

25 Nov 2015 09:00

RNS Number : 8432G
Spirax-Sarco Engineering PLC
25 November 2015
 
25th November 2015Spirax Sarco acquires the business of Flow Smart Inc 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam, and in peristaltic pumping and associated fluid path technologies, announces that it has acquired the business and assets of Flow Smart Inc., (Flow Smart) for £5.7 million from the founding shareholder and partners. 

Flow Smart, based in Seaford, Delaware USA, specialises in the design and manufacture of high purity sanitary gaskets, silicone transfer tubing and reinforced silicone hoses for the bioprocessing and pharmaceutical industries. The business will be integrated into the Watson-Marlow Fluid Technology Group (WMFTG) and we are pleased that Lou Bongiorno, founder and President of Flow Smart, will transfer along with existing staff to our new company, Watson-Marlow Flow Smart, Inc., and continue in his role as President.

Flow Smart is a natural extension and supplement to the WMFTG fluid path product portfolio and further strengthens WMFTG's extensive global presence in the biotechnology and pharmaceutical industries, which includes Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, BioPure single-use tubing connector systems, Aspeco aseptic valves and Alitea OEM Pumps. Flow Smart's product range utilises market-leading technology to improve sterility within the biotechnology production process, thereby reducing validation risk in demanding contamination-free applications and enhancing customer confidence.

The purchase consideration will be paid in cash at completion from the Group's existing resources. The acquisition is expected to generate an immediate small benefit to Group earnings per share.

 

Enquiries:

Nick Anderson, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in each of its two businesses, Spirax Sarco for steam specialties and Watson-Marlow Fluid Technology Group for niche peristaltic pumps and associated fluid path technologies. The steam specialties business provides a broad range of fluid control products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. The company helps its customers to improve production efficiency, reduce energy costs, water usage and emissions, improve product quality and enhance the safety of their operations. Watson-Marlow Fluid Technology Group offers the ideal solution for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance free pumps and associated technologies. The Group is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,800 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX).

Further information can be found at www.spiraxsarcoengineering.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAXFLAALSFFF
Date   Source Headline
1st Jul 20094:19 pmRNSNotice of Results
1st Jul 20093:36 pmRNSTotal Voting Rights
23rd Jun 20099:04 amRNSHolding(s) in Company
22nd Jun 20093:06 pmRNSDirector/PDMR Shareholding
19th Jun 200911:52 amRNSDirector/PDMR Shareholding
15th Jun 20093:28 pmRNSHolding(s) in Company
4th Jun 20098:26 amRNSHolding(s) in Company
3rd Jun 20094:53 pmRNSDirector/PDMR Shareholding
1st Jun 20095:08 pmRNSTotal Voting Rights
28th May 20098:33 amRNSHolding(s) in Company
19th May 20092:39 pmRNSDirector/PDMR Shareholding
12th May 20091:00 pmRNSInterim Management Statement
1st May 200912:12 pmRNSTotal Voting Rights
14th Apr 20094:32 pmRNSHolding(s) in Company
9th Apr 20098:40 amRNSHolding(s) in Company
1st Apr 20098:54 amRNSTotal Voting Rights
30th Mar 20092:10 pmRNSAnnual Report and Accounts
20th Mar 20094:06 pmRNSHolding(s) in Company
18th Mar 20094:04 pmRNSHolding(s) in Company
11th Mar 20094:45 pmRNSDirector/PDMR Shareholding
10th Mar 20093:41 pmRNSDirector/PDMR Shareholding
9th Mar 20097:00 amRNSPreliminary Announcement
2nd Mar 20091:54 pmRNSTotal Voting Rights
18th Feb 200912:22 pmRNSNotice of Results
10th Feb 200912:37 pmRNSDirectorate Change
4th Feb 20099:51 amRNSTotal Voting Rights
5th Jan 200912:49 pmRNSTotal Voting Rights
19th Dec 20085:09 pmRNSTransaction in Own Shares
18th Dec 20085:28 pmRNSTransaction in Own Shares
17th Dec 20085:07 pmRNSTransaction in Own Shares
16th Dec 20085:00 pmRNSTransaction in Own Shares
15th Dec 20085:04 pmRNSTransaction in Own Shares
12th Dec 20084:38 pmRNSTransaction in Own Shares
11th Dec 20084:55 pmRNSTransaction in Own Shares
8th Dec 20085:04 pmRNSTransaction in Own Shares
8th Dec 20088:56 amRNSDirectorate Change
5th Dec 20085:13 pmRNSTransaction in Own Shares
5th Dec 200811:06 amRNSDirector/PDMR Shareholding
4th Dec 20085:11 pmRNSTransaction in Own Shares
4th Dec 20084:06 pmRNSDirector/PDMR Shareholding
3rd Dec 20085:23 pmRNSTransaction in Own Shares
2nd Dec 20085:38 pmRNSTransaction in Own Shares
1st Dec 20085:11 pmRNSTransaction in Own Shares
1st Dec 200811:22 amRNSTotal Voting Rights
28th Nov 20085:03 pmRNSTransaction in Own Shares
27th Nov 20085:16 pmRNSTransaction in Own Shares
26th Nov 20085:06 pmRNSTransaction in Own Shares
25th Nov 20085:27 pmRNSTransaction in Own Shares
24th Nov 20085:39 pmRNSTransaction in Own Shares
21st Nov 20085:19 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.